Cytosorbents
CTSO
#10672
Rank
A$29.43 M
Marketcap
A$0.47
Share price
-1.41%
Change (1 day)
-67.45%
Change (1 year)

Earnings for Cytosorbents (CTSO)

Earnings in 2026 (TTM): -A$18.07 Million

According to Cytosorbents's latest financial reports the company's current earnings are A$37.2 Million. In 2025 the company made an earning of -A$12.01 Million, an increase over its 2024 earnings that were of -A$31.73 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cytosorbents from 2006 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$18.07 Million50.45%
2025 -A$12.01 Million-62.16%
2024 -A$31.73 Million-22.49%
2023 -A$40.93 Million-13.52%
2022 -A$47.33 Million34.04%
2021 -A$35.31 Million182.17%
2020 -A$12.52 Million-55.97%
2019 -A$28.42 Million14.17%
2018 -A$24.89 Million95.14%
2017 -A$12.76 Million-22.32%
2016 -A$16.42 Million39.1%
2015 -A$11.81 Million-12.89%
2014 -A$13.55 Million89%
2013 -A$7.17 Million26.65%
2012 -A$5.67 Million-26.02%
2011 -A$7.66 Million-288.45%
2010 A$4.06 M-4.17%
2009 A$4.23 M-287.19%
2008 -A$2.27 Million-47.12%
2007 -A$4.29 Million41.78%
2006 -A$3.02 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Boston Scientific
BSX
A$5.22 B-30,646.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Hologic
HOLX
A$1.08 B-6,447.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Meridian Bioscience
VIVO.defunct
A$77.47 M-553.11%๐Ÿ‡บ๐Ÿ‡ธ USA